Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Leukemia & Lymphoma|August 10, 2011
High prevalence of hepatitis B virus infection in multiple myelomaBeihui Huang, Juan Li, Zhenhai Zhou, et al.Annals of Medicine|December 17, 2023
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experienceYanjuan Li, Junru Liu, Beihui Huang, et al.Leukemia & Lymphoma|August 8, 2014
Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplantJuan Li, Beihui Huang, Ying Li, et al.Acta Biochimica Et Biophysica Sinica|May 22, 2013
Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteinsBo Lu, Juan Li, Jingxuan Pan, et al.Frontiers in Oncology|February 6, 2023
Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty scoreYadong Chen, Jingli Gu, Beihui Huang, et al.Bioengineered|September 20, 2021
Mechanism of megaloblastic anemia combined with hemolysisQiong Wu, Junru Liu, Xiaoxuan Xu, et al.Cell Biochemistry and Biophysics|October 26, 2014
Drug-induced modulation of T lymphocytes as a potential mechanism of susceptibility to infections in patients with multiple myeloma during bortezomib therapyJuan Li, Ying Li, Beihui Huang, et al.Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|September 1, 2020
Cystathionine β Synthase/Hydrogen Sulfide Signaling in Multiple Myeloma Regulates Cell Proliferation and ApoptosisMinmin Zhang, Juan Li, Beihui Huang, et al.Frontiers in Oncology|June 6, 2022
Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCTQian Sun, Xiaozhe Li, Jingli Gu, et al.Tumori|September 21, 2016
Reduced response of IRE1α/Xbp-1 signaling pathway to bortezomib contributes to drug resistance in multiple myeloma cellsXiaoxuan Xu, Junru Liu, Beihui Huang, et al.Pageof 5